文献速递外周动脉疾病

基于PORTRAIT登记分析早期干预对伴慢性完全闭塞病变的外周动脉疾病患者健康状态结局的影响

Impact of early intervention on health status outcomes in peripheral artery disease patients with chronic total occlusion lesions using the PORTRAIT registry.
PubMed 文献 · J Vasc Surg · 2024-05-10

基于国际多中心PORTRAIT观察性纵向登记,纳入2011年6月至2015年12月近期有症状的下肢外周动脉疾病患者581例,按慢性完全闭塞(CTO)状态和早期侵入性 vs 非侵入性治疗分组,采用倾向性匹配加权和多水平广义线性回归分析12个月健康状态轨迹。结果显示早期侵入性治疗组健康状态评分随时间改善优于非侵入性治疗组,且不受CTO状态影响。

要点

  • 早期侵入性治疗组健康状态评分改善随时间优于非侵入性治疗组(治疗×月份 P < .001),与CTO状态无关。
  • 两组评分改善均在初始访视后3个月内幅度最大。
  • CTO与非CTO组在基线及各时间点的健康状态评分均无显著差异。

核心结论

  • 有症状的外周动脉疾病患者接受早期血运重建者,其健康状态随时间改善优于非侵入性治疗策略,无论是否存在CTO。
  • 健康状态改善程度在初始访视后3个月内更大,尤其在接受早期血运重建的患者中。

研究设计与样本

  • 国际观察性纵向登记(PORTRAIT),纳入美国、荷兰和澳大利亚2011年6月至2015年12月近期有外周动脉疾病症状的患者。
  • 共纳入581例参与者,平均年龄66.62 ± 9.33岁,女性占34.3%,白人占90.8%;无CTO者353例(60.8%),有CTO者228例(39.2%)。
  • 在倾向性匹配加权队列中,按CTO状态和治疗组(早期侵入性:3个月内血运重建 vs 非侵入性:运动、药物治疗或戒烟)比较特征。
  • 采用多水平广义线性回归模型分析12个月健康状态轨迹,校正基线健康状态,设站点和患者水平随机效应。

主要发现

  • 早期侵入性治疗组分别为96例(27.2%)无CTO和70例(30.7%)有CTO(d = 0.07)。
  • CTO患者更可能有较低静息ABI、多水平病变和严重跛行(|d| ≥ 0.20),但基线健康状态与无CTO者无差异,平均汇总评分分别为45.14 ± 20.26 vs 45.90 ± 21.24(d = 0.04)。
  • 健康状态轨迹不因CTO状态而异(CTO状态×月份交互 P = .517),早期侵入性治疗组高于非侵入性治疗组(治疗×月份 P < .001),与CTO状态无关(CTO状态×治疗 P = .981;CTO状态×治疗×月份 P = .264)。
  • 3个月内评分改善最大:非侵入性组无CTO +7.82(95%CI 4.03-11.60),有CTO +9.27(95%CI 4.45-14.09);早期侵入性组无CTO +26.17(95%CI 20.06-32.28),有CTO +24.52(95%CI 17.40-31.64)。
  • 12个月平均评分在CTO vs 非CTO组各时间点无差异:非侵入性治疗组70.26(95%CI 67.87-74.65) vs 71.17(95%CI 65.91-76.44)(P = .99);早期侵入性治疗组84.93(95%CI 78.90-90.97) vs 79.20(95%CI 72.77-86.14)(P = .31)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the impact of noninvasive and early invasive treatments on health status in patients with lower extremity peripheral arterial disease (PAD) without and with chronic total occlusions (CTOs) after 12 months of follow-up. METHODS: Using the international (the United States, the Netherlands, and Australia) observational longitudinal Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories registry, we included patients with recent PAD symptoms between June 2011 and December 2015. We assessed the PAD-specific health status at initial visit and the 3-, 6-, and 12-month follow-up using the Peripheral Arterial Questionnaire. On a propensity matched-weighted cohort, we compared patients' characteristics by CTO status and treatment groups as early invasive (revascularization in the 3 months) vs noninvasive (exercise, medical therapies, or smoking cessation). We then assessed the health status trajectory over 12 months, as a three-way interaction between CTO status, treatment groups, and months, using a multilevel generalized linear regression model for repeated measures adjusted for baseline health status with random effects at the site and patient levels. RESULTS: We included 581 participants, with a mean age of 66.62 ± 9.33 years, 34.3% female, and 90.8% White, of whom 353 (60.8%) were without and 228 (39.2%) had a CTO lesion. Respectively, 96 (27.2%) and 70 (30.7%) patients underwent early invasive treatment (d = 0.07). Although patients with CTO were more likely to have lower resting ABI, multilevel disease, and to experience severe claudication vs their counterparts (|d| ≥ 0.20), patient health status at baseline with CTO was not different from those without CTO, with mean summary scores of 45.14 ± 20.26 vs 45.90 ± 21.24 (d = 0.04), respectively. The trajectory did not differ by CTO status (interaction CTO status × month; P = .517) and was higher in early invasive vs noninvasive treatment (treatment × month; P < .001), regardless of CTO status (CTO status × treatment; P = .981 and CTO status × treatment × month; P = .264). The score increased over time with the largest improvement occurring at 3 months in both noninvasive (non-CTO, +7.82 [95% confidence interval (CI), 4.03-11.60] and CTO, +9.27 95% CI, 4.45-14.09) and early invasive (non-CTO, +26.17 [95% CI, 20.06-32.28] and CTO, +24.52 [95% CI, 17.40-31.64] groups. The mean score in CTO vs non-CTO groups did not differ at each timepoint, with a 12-month mean score of 70.26 (95% CI, 67.87-74.65) vs 71.17 (95% CI, 65.91-76.44) (P = .99) in the noninvasive treatment and 84.93 (95% CI, 78.90-90.97) vs 79.20 (95% CI, 72.77-86.14) (P = .31) in the early invasive treatment. CONCLUSIONS: Patients with symptomatic PAD undergoing early revascularization exhibited better health status over time vs those undergoing noninvasive treatment strategy, irrespective of the presence of CTOs. The degree of the improvement was greater in the 3 months after the initial visit, especially in patients undergoing early revascularization.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cerrud-Rodriguez RC, Romain G, Hussain Y, et al. Impact of early intervention on health status outcomes in peripheral artery disease patients with chronic total occlusion lesions using the PORTRAIT registry. J Vasc Surg. 2024. PMID: 38735596. doi:10.1016/j.jvs.2024.04.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。